Contents

Current Drug Targets, Volume 3 - Number 4

Preface

, 3(4): i

Maria Paola Costi


DOI: 10.2174/1389450023347632




Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling

, 3(4): 281 - 296

A. Lahm, A. Yagnik, A. Tramontano and U. Koch


DOI: 10.2174/1389450023347650




The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger

, 3(4): 297 - 309

Randal W. Berg, Peter J. Ferguson, Janice M. DeMoor, Mark D. Vincent and James Koropatnick


DOI: 10.2174/1389450023347605




Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents

, 3(4): 311 - 333

J. M. Perez-Victoria, A. Di Pietro, D. Barron, A. G. Ravelo, S. Castanys and F. Gamarro


DOI: 10.2174/1389450023347588




Streptogramin Antibiotics: Mode of Action and Resistance

, 3(4): 335 - 344

Nicole J. Johnston, Tariq A. Mukhtar and Gerard D. Wright


DOI: 10.2174/1389450023347678




Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?

, 3(4): 345 - 349

Jesus Blazquez, Antonio Oliver and Jose-Maria Gomez-Gomez


DOI: 10.2174/1389450023347579




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science